Ossami Saidy, R.R.; Postel, M.P.; PflĂĽger, M.J.; Schoening, W.; Ă–llinger, R.; GĂĽl-Klein, S.; Schmelzle, M.; Tacke, F.; Pratschke, J.; Eurich, D.
Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma. Cancers 2021, 13, 1617.
https://doi.org/10.3390/cancers13071617
AMA Style
Ossami Saidy RR, Postel MP, PflĂĽger MJ, Schoening W, Ă–llinger R, GĂĽl-Klein S, Schmelzle M, Tacke F, Pratschke J, Eurich D.
Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma. Cancers. 2021; 13(7):1617.
https://doi.org/10.3390/cancers13071617
Chicago/Turabian Style
Ossami Saidy, Ramin Raul, Maximilian Paul Postel, Michael Johannes PflĂĽger, Wenzel Schoening, Robert Ă–llinger, Safak GĂĽl-Klein, Moritz Schmelzle, Frank Tacke, Johann Pratschke, and Dennis Eurich.
2021. "Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma" Cancers 13, no. 7: 1617.
https://doi.org/10.3390/cancers13071617
APA Style
Ossami Saidy, R. R., Postel, M. P., PflĂĽger, M. J., Schoening, W., Ă–llinger, R., GĂĽl-Klein, S., Schmelzle, M., Tacke, F., Pratschke, J., & Eurich, D.
(2021). Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma. Cancers, 13(7), 1617.
https://doi.org/10.3390/cancers13071617